Stocks · Health care · Pharmaceutical Preparations

Arcus Biosciences, Inc.

RCUS Clue Score44

United States Fiscal year ends December CIK 0001724521 Results filed 4 Nov 2026

Add to watchlist

What the insiders did Scheduled selling only

By person

16 insiders · 37 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Juan C. Jaen

President

—

$7.12M (16) scheduled

−$7.12M

1,199,252

0.9418%

$35.98M

−21.2%

Jennifer Jarrett

Chief Operating Officer

—

$1.42M (3) scheduled

−$1.42M

224,024

0.1759%

$6.72M

+16.8%

Terry J Rosen

Chief Executive Officer

—

$1.20M (2) scheduled

−$1.20M

2,236,409

1.76%

$67.09M

+6.4%

II Robert C. Goeltz

Chief Financial Officer

—

$755.89K (5) scheduled

−$755.89K

84,161

0.0661%

$2.52M

+14.0%

Alexander Azoy

Chief Accounting Officer

—

$395.67K (6) scheduled

−$395.67K

39,581

0.0311%

$1.19M

+69.1%

Carolyn C. Tang

General Counsel

—

$318.50K (2) scheduled

−$318.50K

184,607

0.1450%

$5.54M

+60.1%

Richard Markus

Chief Medical Officer

—

$210.14K (2) scheduled

−$210.14K

89,647

0.0704%

$2.69M

—

Gilead Sciences, Inc. entity

10% owner

—

—

—

31,424,760

24.68%

$942.74M

+4.5%

Nuyten Dimitry SA

Chief Medical Officer

—

—

—

87,518

0.0687%

$2.63M

−8.2%

David L. Lacey

Director

—

—

—

76,652

0.0602%

$2.30M

+33.0%

Andrew J Perlman

Director

—

—

—

48,325

0.0380%

$1.45M

+64.8%

Kathryn E Falberg

Director

—

—

—

44,300

0.0348%

$1.33M

+75.1%

Patrick Machado

Director

—

—

—

44,300

0.0348%

$1.33M

+75.1%

Antoni Ribas

Director

—

—

—

44,300

0.0348%

$1.33M

+46.0%

Nicole Lambert

Director

—

—

—

43,000

0.0338%

$1.29M

+79.2%

Yasunori Kaneko

Director

—

—

—

25,700

0.0202%

$771.00K

—